GNFT,Genfit S.A. | Healthcare - www.financetom.com

Healthcare

GNFT

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Genfit S.A.GNFT

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis.

It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia.

The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA.

The company was incorporated in 1999 and is headquartered in Loos, France.

Latest News >

Marriott Vacations Worldwide Insider Bought Shares Worth $3,984,960, According to a Recent SEC Filing

Nov 19, 2025

05:38 PM EST, 11/19/2025 (MT Newswires) -- Christian Asmar, 10% Owner, Director, on November 19, 2025, executed a purchase for 84,000 shares in Marriott Vacations Worldwide ( VAC ) for $3,984,960. Following the Form 4 filing with the SEC, Asmar has control over a total of 4,130,340 common shares of the company, with 4,130,340 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1524358/000092189525003162/xslF345X05/form412236010_11192025.xml ...

Digi International Insider Sold Shares Worth $852,843, According to a Recent SEC Filing

Nov 19, 2025

05:44 PM EST, 11/19/2025 (MT Newswires) -- David H. Sampsell, Vice President, Corporate Development, Corporate Secretary and General Counsel, on November 17, 2025, sold 22,222 shares in Digi International ( DGII ) for $852,843. Following the Form 4 filing with the SEC, Sampsell has control over a total of 96,613 common shares of the company, with 31,749 shares held directly...

Electronic Arts Insider Sold Shares Worth $502,643, According to a Recent SEC Filing

Nov 19, 2025

05:43 PM EST, 11/19/2025 (MT Newswires) -- Laura Miele, President of EA Entertainment, on November 17, 2025, sold 2,500 shares in Electronic Arts ( EA ) for $502,643. Following the Form 4 filing with the SEC, Miele has control over a total of 55,648 common shares of the company, with 55,648 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/712515/000071251525000087/xslF345X05/form4.xml ...

Agora Swings to Q3 Earnings, Revenue Rise; Q4 Revenue Outlook Set

Nov 19, 2025

05:41 PM EST, 11/19/2025 (MT Newswires) -- Agora (API) reported a Q3 net income of $0.03 per American depositary share, swinging from a loss of $0.23 a year earlier. Revenue for the quarter ended Sept. 30 was $35.4 million, up from $31.6 million a year earlier. The company said it expects Q4 revenue between $37 million and $38 million. Comparable...